Steven Caras

712 total citations
18 papers, 454 citations indexed

About

Steven Caras is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Steven Caras has authored 18 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Steven Caras's work include Cystic Fibrosis Research Advances (5 papers), Pancreatitis Pathology and Treatment (5 papers) and Gastrointestinal motility and disorders (4 papers). Steven Caras is often cited by papers focused on Cystic Fibrosis Research Advances (5 papers), Pancreatitis Pathology and Treatment (5 papers) and Gastrointestinal motility and disorders (4 papers). Steven Caras collaborates with scholars based in United States, Germany and Ukraine. Steven Caras's co-authors include Suntje Sander‐Struckmeier, Glen A. Lehman, David C. Whitcomb, Ewa Małecka‐Panas, G. A. VASIL'EVA, Yan Shen, N. B. Gubergrits, Gavin R. Graff, Richard W. McCallum and Karen Maguiness and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Steven Caras

18 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Caras United States 11 300 161 88 87 69 18 454
Tsuguo Sakamoto Japan 12 297 1.0× 106 0.7× 67 0.8× 41 0.5× 236 3.4× 44 544
Jianzhong Di China 16 405 1.4× 102 0.6× 16 0.2× 218 2.5× 121 1.8× 33 652
Heidi Karpen United States 6 118 0.4× 26 0.2× 56 0.6× 55 0.6× 48 0.7× 14 318
N Pandolfo Italy 11 287 1.0× 136 0.8× 202 2.3× 61 0.7× 151 2.2× 27 493
Göran Lundegårdh Sweden 13 765 2.5× 55 0.3× 247 2.8× 99 1.1× 318 4.6× 18 963
H. David Watts United States 8 184 0.6× 53 0.3× 175 2.0× 136 1.6× 67 1.0× 9 442
Fabio Bioletto Italy 13 197 0.7× 20 0.1× 18 0.2× 89 1.0× 79 1.1× 66 531
Rajiv Lahiri United Kingdom 7 181 0.6× 56 0.3× 6 0.1× 49 0.6× 52 0.8× 16 312
Beverly A. Jones United States 8 178 0.6× 107 0.7× 19 0.2× 42 0.5× 62 0.9× 11 333
Peter Myrenfors Sweden 7 200 0.7× 44 0.3× 6 0.1× 140 1.6× 34 0.5× 13 364

Countries citing papers authored by Steven Caras

Since Specialization
Citations

This map shows the geographic impact of Steven Caras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Caras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Caras more than expected).

Fields of papers citing papers by Steven Caras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Caras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Caras. The network helps show where Steven Caras may publish in the future.

Co-authorship network of co-authors of Steven Caras

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Caras. A scholar is included among the top collaborators of Steven Caras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Caras. Steven Caras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Forßmann, K, et al.. (2011). Administration of CREON® Pancrelipase Pellets via Gastrostomy Tube is Feasible with No Loss of Gastric Resistance or Lipase Activity. Clinical Drug Investigation. 31(7). e1–e7. 13 indexed citations
3.
Małecka‐Panas, Ewa, Glen A. Lehman, G. A. VASIL'EVA, et al.. (2011). A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery. Alimentary Pharmacology & Therapeutics. 33(10). 1152–1161. 75 indexed citations
4.
Graff, Gavin R., John McNamara, James A. Royall, Steven Caras, & K Forßmann. (2010). Safety and Tolerability of a New Formulation of Pancrelipase Delayed-Release Capsules (CREON®) in Children Under Seven Years of Age with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis. Clinical Drug Investigation. 30(6). 351–364. 22 indexed citations
5.
Whitcomb, David C., Ewa Małecka‐Panas, N. B. Gubergrits, et al.. (2010). Effect of Underlying Disease Type on Efficacy and Safety of Pancrelipase Delayed-Release Capsules (CREON®) in a Randomized Trial of Patients with Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis or Pancreatic Surgery. The American Journal of Gastroenterology. 105. S51–S52. 1 indexed citations
6.
Kuhn, Robert J., Andrés Gelrud, À. Munck, & Steven Caras. (2010). CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency. Advances in Therapy. 27(12). 895–916. 23 indexed citations
7.
Whitcomb, David C., Glen A. Lehman, G. A. VASIL'EVA, et al.. (2010). Pancrelipase Delayed-Release Capsules (CREON) for Exocrine Pancreatic Insufficiency due to Chronic Pancreatitis or Pancreatic Surgery: A Double-Blind Randomized Trial. The American Journal of Gastroenterology. 105(10). 2276–2286. 126 indexed citations
8.
Trapnell, Bruce C., et al.. (2009). Efficacy and safety of Creon® 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis. Journal of Cystic Fibrosis. 8(6). 370–377. 61 indexed citations
9.
Sander‐Struckmeier, Suntje, et al.. (2009). CREON®: efficacy and safety in children less than 7 years old with exocrine pancreatic insufficiency due to cystic fibrosis. Journal of Cystic Fibrosis. 8. S80–S80. 1 indexed citations
10.
Trapnell, B.C., et al.. (2009). Efficacy and safety of a new formulation of CREON® in patients with exocrine pancreatic insufficiency due to CF. Journal of Cystic Fibrosis. 8. S80–S80. 4 indexed citations
11.
Olden, Kevin W., et al.. (2004). CILANSETRON IMPROVES HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA PREDOMINANCE (IBS-D). The American Journal of Gastroenterology. 99. S277–S277. 3 indexed citations
12.
Miner, Philip B., et al.. (2004). CILANSETRON IN IRRITABLE BOWEL SYNDROME WITH DIARRHEA PREDOMINANCE (IBS-D). The American Journal of Gastroenterology. 99. S277–S277. 19 indexed citations
13.
14.
Caras, Steven, et al.. (2001). Cilansetron shows efficacy in male and female non-constipated patients with irritable bowel syndrome in a United States study. Gastroenterology. 120(5). A217–A217. 29 indexed citations
15.
Caras, Steven. (1999). Gastric Myoelectric Activity in Patients with End-Stage Liver Disease. Scandinavian Journal of Gastroenterology. 34(9). 883–888. 4 indexed citations
16.
Caras, Steven, et al.. (1997). The effect of intravenous vasopressin on gastric myoelectrical activity in human subjects. Neurogastroenterology & Motility. 9(3). 151–156. 31 indexed citations
17.
Caras, Steven, et al.. (1996). Pancreatic Cancer Presenting With Paraneoplastic Gastroparesis. The American Journal of the Medical Sciences. 312(1). 34–36. 19 indexed citations
18.
Caras, Steven, et al.. (1996). Pancreatic Cancer Presenting With Paraneoplastic Gastroparesis. The American Journal of the Medical Sciences. 312(1). 34–36. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsuguo Sakamoto Breakdown of academic impact, for papers by Jianzhong Di Breakdown of academic impact, for papers by Heidi Karpen Breakdown of academic impact, for papers by N Pandolfo Breakdown of academic impact, for papers by Göran Lundegårdh Breakdown of academic impact, for papers by H. David Watts Breakdown of academic impact, for papers by Fabio Bioletto Breakdown of academic impact, for papers by Rajiv Lahiri Breakdown of academic impact, for papers by Beverly A. Jones Breakdown of academic impact, for papers by Peter Myrenfors
Rankless by CCL
2026